Characteristics of MCL cell lines in CD74/CD20 treatment evaluation
| Characteristic . | MCL cell line status . | |||||
|---|---|---|---|---|---|---|
| Jeko . | Mino . | SP-53 . | Rec-1 . | HBL-2 . | Granta . | |
| Doubling time, h | 36-48 | 48 | 48-72 | 38 | 48 | 48-72 |
| Epstein-Barr virus | − | − | − | − | − | + |
| Cyclin D1 expression | + | + | + | + | + | + |
| Evidence of t(11;14) | + | + | + | + | + | + |
| p53 expression | − | + | + | + | + | + |
| Characteristic . | MCL cell line status . | |||||
|---|---|---|---|---|---|---|
| Jeko . | Mino . | SP-53 . | Rec-1 . | HBL-2 . | Granta . | |
| Doubling time, h | 36-48 | 48 | 48-72 | 38 | 48 | 48-72 |
| Epstein-Barr virus | − | − | − | − | − | + |
| Cyclin D1 expression | + | + | + | + | + | + |
| Evidence of t(11;14) | + | + | + | + | + | + |
| p53 expression | − | + | + | + | + | + |
+ indicates presence; and −, absence.